NICOLE SMITH: Open Payments
NPI 1225736325 · BATESVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 27 payments from 8 companies in 2025. Trend: 2023 $294 · 2024 $149 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $157 |
| ABBVIE INC. | 5 | $99 |
| Axsome Therapeutics, Inc. | 5 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $59 |
| Lundbeck LLC | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Alkermes, Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: VRAYLAR, INVEGA SUSTENNA, REXULTI, Auvelity, SPRAVATO, CAPLYTA, ARISTADA, COBENFY.
Industry payments across AR — which companies pay providers there.
